Skip to main content
. Author manuscript; available in PMC: 2008 Nov 25.
Published in final edited form as: J Aging Health. 2008 Mar;20(2):198–216. doi: 10.1177/0898264307310464

Table 5.

Predictors of Use of Nonprescription Analgesics, NSAIDs, and Cox-2 Inhibitors, Osteoarthritis Cohort

Correlate Nonprescription Analgesic NSAIDs Cox-2 Inhibitor
White 1.0 1.0 1.0
African American 1.39 (0.96, 2.0)+ 0.61 (0.41, 0.90)** 0.71 (0.46, 1.08)
Male 1.0 1.0 1.0
Female 1.07 (0.75, 1.5) 1.19 (0.81, 1.76) 1.81 (1.2, 2.8)**
Mild-moderate OA 1.0 1.0 1.0
Severe OA 1.01 (0.69, 1.47) 1.13 (0.76, 1.69) 0.86 (0.56, 1.32)
Age 0.99 (0.96, 1.02) 0.95 (0.92, 0.99)* 0.98 (0.95, 1.02)
Pain scale, 1–10 1.09 (1.0, 1.17)* 0.98 (0.91, 1.06) 1.08 (0.99, 1.17)
Education 0.93 (0.78, 1.12) 1.07 (0.88, 1.31) 1.06 (0.85, 1.31)
Hard-to-access Rx med 1.0 1.0 1.0
No difficulty 0.91 (0.61, 1.36) 1.08 (0.71, 1.66) 1.15 (0.72, 1.84)
Model χ2 13.8 (p = .05) 18.6 (p = .01) 14.8 (p = .04)

Note: Results from logistic regression models, n = 551.

+

p = .08.

*

p < .05.

**

p < .01.